Literature DB >> 9176083

Influence of changes in pancreatic tissue morphology and capillary blood flow on antibiotic tissue concentrations in the pancreas during the progression of acute pancreatitis.

T Foitzik1, H G Hotz, M Kinzig, F Sörgel, H J Buhr.   

Abstract

BACKGROUND: The ability of an antibiotic to reach bactericidal concentrations in tissue depends on numerous factors including tissue composition and regional perfusion. Although necrotising pancreatitis is characterised by progression of pancreatic necrosis over at least 96 hours and microcirculatory alterations, the impact of these changes on the concentration of antibiotics in the pancreas has not yet been investigated. AIM: To determine and compare pancreatic tissue concentrations of imipenem and cefotaxime at different stages of acute necrotising pancreatitis in an animal model that has been shown to mimic closely the pathomorphological and bacteriological features of severe human pancreatitis.
METHOD: Acute necrotising pancreatitis was induced in rats by a standardised intraductal infusion of glycodeoxycholic acid and intravenous cerulein. Six hours (n = 16) and 48 hours (n = 16) after induction of pancreatitis, the animals were randomised for intravenous therapy with either imipenem or cefotaxime. Fifteen minutes after injection of the antibiotic, the animals were killed. Blood and the head of the pancreas were collected for determining imipenem or cefotaxime in serum and tissue; the splenic portion of the pancreas was prepared for histological examination. In an additional set of identically treated animals, pancreatic capillary blood flow (PCBF) was assessed by intravital microscopy before induction of acute necrotising pancreatitis and at the time of antibiotic therapy.
RESULTS: Imipenem accumulates in the pancreas in the initial phase of acute necrotising pancreatitis characterised by pronounced oedema and decreased PCBF, and tends to decrease with resolution of the oedema and the progression of acinar cell necrosis in the later course of the disease. Concentrations of cefotaxime are low in oedematous pancreatic tissue early after induction of acute necrotising pancreatitis and increase with the resolution of oedema and normalisation of PCBF.
CONCLUSIONS: Concentrations of antibiotics in the pancreas vary in acute necrotising pancreatitis, depending on changes in pancreatic tissue morphology and capillary blood flow. This suggests that antibiotic tissue concentrations may not be consistent from one agent to another and that efficacy of antibiotics in acute pancreatitis cannot be estimated solely on the basis of their pharmacological and microbiological properties.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176083      PMCID: PMC1027130          DOI: 10.1136/gut.40.4.526

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  Evaluation of prophylactic antibiotics in acute pancreatitis.

Authors:  R Howes; G D Zuidema; J L Cameron
Journal:  J Surg Res       Date:  1975-02       Impact factor: 2.192

2.  Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid.

Authors:  R A Walstad; K B Hellum; S Blika; L G Dale; T Fredriksen; K I Myhre; G R Spencer
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

3.  Penetration of cefotaxime into the pancreas.

Authors:  P G Lankisch; N Klesel; K Seeger; G Seidel; K Winckler
Journal:  Z Gastroenterol       Date:  1983-10       Impact factor: 2.000

Review 4.  Pharmacokinetics of tissue penetration of antibiotics.

Authors:  T Bergan
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

5.  Principles of tissue penetration of antibiotics.

Authors:  M Barza
Journal:  J Antimicrob Chemother       Date:  1981-11       Impact factor: 5.790

6.  Improvement of pancreatic capillary blood flow does not augment the pancreatic tissue concentration of imipenem in acute experimental pancreatitis.

Authors:  T Foitzik; H G Hotz; M Kinzig; F Sörgel; E Klar; A L Warshaw; H J Buhr
Journal:  Eur Surg Res       Date:  1996       Impact factor: 1.745

7.  Bacterial contamination of pancreatic necrosis. A prospective clinical study.

Authors:  H G Beger; R Bittner; S Block; M Büchler
Journal:  Gastroenterology       Date:  1986-08       Impact factor: 22.682

8.  Comparison study of the kinetics of ceftizoxime penetration into extravascular spaces with known surface area/volume ratio in vitro and in vivo in rabbits.

Authors:  L L Van Etta; C E Fasching; L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

9.  A prospective study to determine the efficacy of antibiotics in acute pancreatitis.

Authors:  W T Finch; J L Sawyers; S Schenker
Journal:  Ann Surg       Date:  1976-06       Impact factor: 12.969

10.  A problem in the interpretation of beta-lactam antibiotic levels in tissues.

Authors:  D M Ryan; O Cars
Journal:  J Antimicrob Chemother       Date:  1983-09       Impact factor: 5.790

View more
  4 in total

1.  Influence of splanchnic vascular infusion on the content of endotoxins in plasma and the translocation of intestinal bacteria in rats with acute hemorrhage necrosis pancreatitis.

Authors:  Ren-Yi Qin; Sheng-Quan Zou; Zai-De Wu; Fa-Zu Qiu
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 2.  Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis.

Authors:  Eduardo Villatoro; Mubashir Mulla; Mike Larvin
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

3.  Changes in antibiotic distribution due to pancreatitis.

Authors:  Kent J Fanning; Thomas A Robertson; Johannes B Prins; Michael S Roberts
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

4.  Effects of Chai-Qin-Cheng-Qi Decoction on cefotaxime in rats with acute necrotizing pancreatitis.

Authors:  Li-Hui Deng; Da-Kai Xiang; Ping Xue; Hai-Yan Zhang; Lei Huang; Qing Xia
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.